Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
Li-Tzong Chen, Do-Youn Oh, Min-Hee Ryu, Kun-Huei Yeh, Winnie Yeo, Roberto Carlesi, Rebecca Cheng, Jongseok Kim, Mauro Orlando, Yoon-Koo Kang
Cancer Res Treat. 2017;49(4):851-868.   Published online 2017 Jan 3     DOI: https://doi.org/10.4143/crt.2016.176
Citations to this article as recorded by Crossref logo
Upregulation of Linc-ROR Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells Through miR-212-3p/FGF7 Axis
Yanjun Mi, Yongwen Li, Zhuo He, Donghan Chen, Qingqi Hong, Jun You
Cancer Management and Research.2021; Volume 13: 899.     CrossRef
Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway
Shucheng Chen, Lan Yao
Cancer Chemotherapy and Pharmacology.2021; 88(2): 323.     CrossRef
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial
Masatoshi Kudo, Takuji Okusaka, Kenta Motomura, Izumi Ohno, Manabu Morimoto, Satoru Seo, Yoshiyuki Wada, Shinpei Sato, Tatsuya Yamashita, Masayuki Furukawa, Takeshi Aramaki, Seijin Nadano, Kazuyoshi Ohkawa, Hirofumi Fujii, Toshihiro Kudo, Junji Furuse, Hi
Journal of Gastroenterology.2020; 55(6): 627.     CrossRef
The Correlation between EGFR and Androgen Receptor Pathways: A Novel Potential Prognostic Marker in Gastric Cancer
Shahrzad S. Fard, Kioomars Saliminejad, Masoud Sotoudeh, Niloofar Soleimanifard, Shaghayegh Kouchaki, Mansour Yazdanbod, Habibollah Mahmoodzadeh, Ardeshir Ghavamzadeh, Reza Malekzadeh, Bahram Chahardouli, Kamran Alimoghaddam, Seyed H. Ghaffari
Anti-Cancer Agents in Medicinal Chemistry.2020; 19(17): 2097.     CrossRef
Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis
Alessandro Rizzo, Veronica Mollica, Angela Dalia Ricci, Ilaria Maggio, Maria Massucci, Fabiola Lorena Rojas Limpe, Francesca Di Fabio, Andrea Ardizzoni
Future Oncology.2020; 16(2): 4409.     CrossRef
S-1 plus apatinib as first-line palliative treatment for stage IVB gastroesophageal junction adenocarcinoma
Chu Zhang, Guang-Mao Yu, Miao Zhang, Dong Liu
Medicine.2020; 99(1): e18691.     CrossRef
An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)
Xiang Wang, Ruixing Zhang, Nan Du, Mudan Yang, Aimin Zang, Likun Liu, Junyan Yu, Jinghua Gao, Junping Zhang, Zhanzhao Fu, Yuchuan Ren, Liwen Ma, Jun Guo, Qingshan Li, Xiaomei Li, Zaiwen Fan, Xiang Song, Zheng Liu, Yan Zhang, Guozhong Li, Zhonghe Yu, Jianf
Therapeutic Advances in Medical Oncology.2020; 12: 175883592090542.     CrossRef
The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis
Jia-Yong Liu, Bao-Rang Zhu, Yu-Dong Wang, Xin Sun
International Journal of Clinical Oncology.2020; 25(6): 1195.     CrossRef
Clinical efficacy and safety of apatinib as maintenance treatment in patients with advanced esophageal squamous cell carcinoma
Guohui Liu, Yanbo Wang, Chunbo Wang, Yunlong He, Mingyan E
Expert Review of Clinical Pharmacology.2020; 13(12): 1423.     CrossRef
Effective Treatment of Cytotoxic Agent Refractory Alpha-Fetoprotein-Producing Gastric Cancer with Ramucirumab: a Case Report and Review of the Literature
Jun Takada, Hiroshi Araki, Noritaka Ozawa, Tomohiko Sugiyama, Masaya Kubota, Takashi Ibuka, Masahito Shimizu
Journal of Gastrointestinal Cancer.2019; 50(3): 556.     CrossRef
Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response
Vineet Govinda Gupta, Ranga Rao Rangaraju, Rajat Saha, Peush Bajpai
Journal of Gastrointestinal Cancer.2019; 50(4): 943.     CrossRef
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
Letizia Procaccio, Vera Damuzzo, Francesca Di Sarra, Alberto Russi, Federica Todino, Vincenzo Dadduzio, Francesca Bergamo, Alessandra Anna Prete, Sara Lonardi, Hans Prenen, Angelo Claudio Palozzo, Fotios Loupakis
Drug Safety.2019; 42(2): 159.     CrossRef
VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer
Lian Lian, Xiang-Li Li, Meng-Dan Xu, Xian-Min Li, Meng-Yao Wu, Yan Zhang, Min Tao, Wei Li, Xiao-Ming Shen, Chong Zhou, Min Jiang
BMC Cancer.2019;[Epub]     CrossRef
STUDY OF VEGF-A AND TGF-Β LEVELS IN BIOPTATES OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND MOUTH FLOOR MUCOSA IN POLYCHEMOTHERAPY WITH MONOCLONAL ANTIBODIES – CETUXIMAB
O. I. Kit, E. M. Frantsiyants, I. V. Neskubina, L. Yu. Vladimirova, A. A. Lyanova, Yu. A. Pogorelova, E. V. Shalashnaya, M. A. Еngibaryan, Yu. S. Sidorenko
Research and Practical Medicine Journal.2019; 6(3): 20.     CrossRef
Tumor progression-dependent angiogenesis in gastric cancer and its potential application
Hsi-Lung Hsieh, Ming-Ming Tsai
World Journal of Gastrointestinal Oncology.2019; 11(9): 686.     CrossRef
Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours
Guohui Liu, Chunbo Wang, Yunlong He, Mingyan E
BMC Pharmacology and Toxicology.2019;[Epub]     CrossRef
N -methyl- N -nitro- N -nitrosoguanidine-mediated ING4 downregulation contributed to the angiogenesis of transformed human gastric epithelial cells
Yansu Chen, Rui Fu, Mengdie Xu, Yefei Huang, Guixiang Sun, Lichun Xu
Life Sciences.2018; 199: 179.     CrossRef
GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis
Keshuo Ding, Sheng Tan, Xing Huang, Xiaonan Wang, Xiaocan Li, Rong Fan, Yong Zhu, Peter E. Lobie, Wenbin Wang, Zhengsheng Wu
Journal of Biological Chemistry.2018; 293(11): 3949.     CrossRef
Nanoparticles designed to regulate tumor microenvironment for cancer therapy
Min Li, Fangrong Zhang, Yujie Su, Jianping Zhou, Wei Wang
Life Sciences.2018; 201: 37.     CrossRef
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Xiaodong Wang, Yu Liu, Yuwen Diao, Ningning Gao, Yanyan Wan, Jingjing Zhong, Huali Zheng, Zhulin Wang, Guangyi Jin
Journal of Translational Medicine.2018;[Epub]     CrossRef
ASO Author Reflections: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Gastric Cancer
In-Hwan Kim
Annals of Surgical Oncology.2018; 25(S3): 749.     CrossRef
Identification of Bone Metastasis-associated Genes of Gastric Cancer by Genome-wide Transcriptional Profiling
Mingzhe Lin, Xin Li, Haizhou Guo, Faxiang Ji, Linhan Ye, Xuemei Ma, Wen Cheng
Current Bioinformatics.2018; 14(1): 62.     CrossRef
Antiangiogenic effects of oridonin
Lili Tian, Kangjie Xie, Donglai Sheng, Xiaoqing Wan, Guofu Zhu
BMC Complementary and Alternative Medicine.2017;[Epub]     CrossRef
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane, Arielle Rowe, Nicholas Ekow Thomford, Hendrina Shipanga, Daniella Munro, Mohammad A. M. Al Mazeedi, Hashim A. M. Almazyadi, Karlien Kallmeyer, Collet Dandara, Michael S. Pepper, M. Iqbal Parker, Kevin Dzobo
International Journal of Molecular Sciences.2017; 18(7): 1586.     CrossRef
Efficacy and safety for Apatinib treatment in advanced gastric cancer: a real world study
Yong Zhang, Chun Han, Juan Li, Li Zhang, Lijie Wang, Sisi Ye, Yi Hu, Li Bai
Scientific Reports.2017;[Epub]     CrossRef
Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
Henrik Nienhüser, Thomas Schmidt
International Journal of Molecular Sciences.2017; 19(1): 43.     CrossRef